Golden State Equity Partners’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.88K Buy
+90
New +$3.32K ﹤0.01% 1810
2026
Q2
– Sell
-120
Closed -$4.62K – 600
2026
Q1
$4.62K Buy
+120
New +$4.43K ﹤0.01% 1489

Other funds holding COGT

Golden State Equity Partners's COGT Position: Q3 2026 in Review

Golden State Equity Partners opened a new position in Cogent Biosciences (COGT) in Q3 2026: 90 shares worth $2.88K. The stake represents ﹤0.01% of the portfolio and ranks #1810 among its holdings. This is a return to the name: Golden State Equity Partners previously reported a position in COGT as recently as Q1 2026.

Golden State Equity Partners first reported a position in COGT in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.62K in Q1 2026. 314 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Golden State Equity Partners held 90 shares of Cogent Biosciences worth $2.88K as of Q3 2026.
  • Cogent Biosciences was a new Golden State Equity Partners position in Q3 2026.
  • Cogent Biosciences made up ﹤0.01% of Golden State Equity Partners's portfolio in Q3 2026, its #1810 holding.
  • Golden State Equity Partners first reported a position in Cogent Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Golden State Equity Partners's Cogent Biosciences position peaked at $4.62K in Q1 2026.
  • 314 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Golden State Equity Partners's 13F filing for Q3 2026, filed 3 Nov 2026.